Chronic neutrophilic leukemia, a rare case of leukocytosis
- 1 July 2020
- journal article
- letter
- Published by Elsevier in Leukemia Research
- Vol. 94, 106384
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Mutation landscape in patients with myelofibrosis receiving ruxolitinib or hydroxyureaBlood Cancer Journal, 2018
- Chronic neutrophilic leukemia: new science and new diagnostic criteriaBlood Cancer Journal, 2018
- Impact of genomic alterations on outcomes in myelofibrosis patients undergoing JAK1/2 inhibitor therapyBlood Advances, 2017
- Ruxolitinib, a potent JAK1/JAK2 inhibitor, induces temporary reductions in the allelic burden of concurrent CSF3R mutations in chronic neutrophilic leukemiaHaematologica, 2017
- Changes in allele frequencies of CSF3R and SETBP1 mutations and evidence of clonal evolution in a chronic neutrophilic leukemia patient treated with ruxolitinibHaematologica, 2017
- Genomics of chronic neutrophilic leukemiaBlood, 2017
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemiaBlood, 2016
- Correlation of mutation profile and response in patients with myelofibrosis treated with ruxolitinibBlood, 2015
- The Natural History of CSF3R-Mutated Chronic Neutrophilic Leukemia: A Mayo Clinic Series of 14 Consecutive CasesBlood, 2014
- OncogenicCSF3RMutations in Chronic Neutrophilic Leukemia and Atypical CMLNew England Journal of Medicine, 2013